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Recent evidence supports a role for vitamin K-dependent coagulation zymogens in adenovirus serotype 5
(Ad5, subgroup C) infection of hepatocytes. Here, we assessed the effect of virus-zymogen interaction on
cellular transduction using a panel of fiber (f)-pseudotyped viruses derived from subgroup D (f47, f33, f24, f45,
f17, f30). Each virus directly bound factor X (FX) as determined by surface plasmon resonance, resulting in
enhanced cell surface binding. Infection of HepG2 cells was promoted by FX but not by FVII or FIX, while
transduction of CHO cells was blocked in heparan sulfate proteoglycan-deficient cells. This suggests a broad
role for FX in adenovirus infectivity.
Adenoviral vectors, particularly adenovirus serotype 5 (Ad5,
subgroup C virus), are used routinely for gene therapy in the
experimental setting and are being tested extensively in the
clinical setting. In vitro, Ad5 binds to cells predominantly
through primary interaction with the coxsackie virus and ade-
novirus receptor (3, 18) and internalization through integrin
engagement (19). The profound in vivo infectivity of Ad5 for
the liver following systemic delivery, however, is dictated by the
virus binding to coagulation zymogens, including factor IX
(FIX) (16) and FX (15). This is particularly relevant for un-
derstanding adenovirus infectivity following intravascular ad-
ministration, since the virus comes into immediate contact with
blood cells (14) and circulating proteins. For efficient retarget-
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FIG. 1. Subgroup D viruses and surface plasmon resonance analysis of FX-virus binding. (A) Phylogenetic depiction of subgroup D viruses,
adapted from previous work (9). (B) Adenovirus Ad5/f45 was perfused over FX, and FXI was immobilized onto a CM5 sensor chip in 50 mM Tris
(pH 7.4), 150 mM NaCl, 5 mM CaCl2, 0.005% Tween 20 at a flow rate of 20 l/m at 25°C. Shown are typical sensorgrams indicating an association
with FX but not FXI and an undetectable dissociation of the virus from FX following the end of the injection but a ready dissociation upon injection
of 3 mM EDTA. RU, response units.
3627
 o
n
 February 25, 2014 by Cardiff Univ
http://jvi.asm.org/
D
ow
nloaded from
 
ing of Ad5-based gene delivery vectors to alternate sites
(e.g.,disseminated cancers, alternate organs, and specific sites
of disease that lack medically achievable surgical access), it is
likely that modulation of this pathway will be required, since
binding of coagulation factors to the virus is efficient (15).
Previous studies have suggested that the fiber is the major
determinant of FIX binding to the capsid (16). A simple
method, therefore, to alter susceptibility to coagulation factor
binding may be to use fibers derived from alternate serotypes
and pseudotyped onto the Ad5 capsid. Shayakhmetov and co-
workers demonstrated that Ad5 capsids possessing the fiber of
serotype 35 (subgroup B) showed enhancement of cell infec-
tion mediated by FIX (16). Subgroup D-based Ads, either as
pseudotyped viruses or as complete serotype viruses, are being
developed for a variety of clinical applications, including tar-
FIG. 2. Effect of physiological FX concentrations on Ad-mediated binding and transduction of HepG2 cells. HepG2 cells were infected with
each Ad (1,000 viral particles/cell) in the absence or presence of physiological levels of FX for various times in serum-free medium. (A) Cell binding
analysis by TaqMan of recovered viral genomes following exposure to cells at 4°C for 1 h. Representative TaqMan traces are shown for Ad5/f17
and Ad5/f47 in the presence and absence of FX. u.i., uninfected cells; Rn, change in normalized fluorescence. (B) Cell transduction by luciferase
and total protein quantification at 72 h postinfection following exposure to FX for 3 h at 37°C. , P  0.05 versus virus in the absence of FX; #,
P  0.01 versus virus in the absence of FX (Student’s t test). The numbers above the bars represent the changes (n-fold) in comparison with the
value in the absence of FX. This figure is representative of three independent experiments. RLU, relative light units.
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geted in vivo gene delivery and vaccination (5, 12). Additional
virological importance may be assigned to coagulation factor
binding, since adenovirus infections are relatively common
(and heterogeneous with respect to adenovirus subgroups, in-
cluding subgroup D) in immunocompromised patients (13).
Many of the receptors for adenoviruses from this subgroup
remain to be isolated, and those that have been characterized
often bind with relatively low affinity (1, 2, 4, 5). Since virus
exposure to the blood and hence dissemination may occur in a
number of such applications, it is important to assess coagula-
tion factor binding capacity. We documented this capacity by
using a panel of luciferase-expressing Ad5 vectors pseudotyped
with fibers from subgroup D, including f17, f24, f30, f33, f45,
and f47 (see Fig. 1A for a phylogenetic depiction) (7–9).
We first screened viruses for coagulation factor binding by
using surface plasmon resonance. We used biosensor chips
with immobilized FX or FXI (negative control) (15). All vi-
ruses bound to FX but not to FXI (see Fig. 1B for Ad5/f45 as
an example). In each case, and consistent with previous data
for Ad5 (15), no dissociation of virus from FX was observed
until 3 mM EDTA was added, indicating a strong and calcium-
dependent interaction with FX (see Fig. 1B for Ad5/f45 as an
example). This demonstrates that all viruses evaluated directly
bind to FX.
We next sought to determine whether physiological concen-
trations of FX could influence HepG2 cell binding and trans-
duction mediated by each pseudotyped adenovirus in vitro.
Previously we have used this in vitro model as a reproducible
model system to examine the effect of coagulation factors on
human cell transduction (15). We exposed cells and viruses to
physiological concentrations of FX (10 g/ml, 1 IU/ml) in
serum-free medium for 1 h at 4°C (for cell binding studies) or
for 3 h at 37°C followed by incubation for 72 h (for transduc-
tion studies). All subgroup D fiber-pseudotyped vectors
showed a significant increase in cell binding (Fig. 2A) and
subsequent transgene expression (Fig. 2B) in HepG2 cells in
the presence of FX, ranging from a 3.7-fold increase in trans-
duction in the presence of FX for serotype Ad5/f30 to a 24.9-
fold increase for Ad5/f33 (Fig. 2B). This demonstrates that
physiological FX concentrations substantially enhance cell
binding and transduction of HepG2 cells mediated by each
subgroup D fiber-pseudotyped virus.
To further investigate the effect of other coagulation factors
with the -carboxyglutamic acid–epidermal growth factor-like
(EGF)–EGF–serine protease domain structure on virus trans-
duction, we transduced HepG2 cells with a subset of viruses,
Ad5/f47, Ad5/f33, and Ad5/f30, in the presence of physiologi-
cal concentrations of FVII, FIX, FX, or FXI (negative control)
(Fig. 3). All reagents were purified proteins obtained from
Hematological Technologies, Ltd., except FVII, which was re-
combinant (15). All subgroup D-pseudotyped viruses showed a
substantial enhancement of HepG2 cell transduction in the
presence of FX but not with FVII, FIX, or FXI (Fig. 3). The
lack of effect of FVII and FIX was surprising based on previous
observations for Ad5 (15, 16) and for the subgroup B Ad35
(16). Although further experiments may be required to assess
direct interactions of individual coagulation factors and each
virus as well as recombinant forms of FIX, these data do
suggest potential subgroup-specific differences in fiber-coagu-
lation factor interactions.
We hypothesized that the increase in transduction mediated
through FX would be via an interaction with heparan sulfate
proteoglycan (HSPG), as observed for Ad5 (15, 16); therefore,
CHO cell infections were performed for each virus. CHO-K1
cells (wild type) express HSPGs, whereas CHO-pgsA745 cells
have been genetically modified to be deficient in polymeriza-
tion of HSPGs and therefore have no cell surface expression
(6). In each case, physiological levels of FX enhanced trans-
duction in CHO-K1 cells (Fig. 4). However, this level was
significantly reduced for CHO-pgsA745 cells (Fig. 4). There-
fore, for subgroup D fiber-pseudotyped viruses that show an
enhancement in cell binding and transduction through FX, the
virus is targeted through HSPG, consistent with the mecha-
nism of retargeting of Ad5 (15, 16). It is noteworthy that the
putative HSPG binding site in the third pseudorepeat of the
Ad5 fiber (17) is not present in any of the pseudotypes here.
However, we recently demonstrated that Ad5 fibers mutated at
this site (KKTK motif) show efficient binding to FX (11).
Taken together, these data suggest that Ad5 and subgroup D
fiber-pseudotyped Ads that are responsive to FX mediate en-
FIG. 3. Effects of FVII, FIX, and FX on transduction of HepG2 cells.
HepG2 cells were incubated with 1 IU/ml of human FVII, FIX, or FX or
the divergent control zymogen FXI in the absence or presence of each Ad
(1,000 viral particles/cell) for 3 h. Transgene expression was quantified at
72 h postinfection and normalized to the total protein content. , P 0.05
versus virus in the absence of FX; #, P 0.01 versus virus in the absence
of FX (Student’s t test). This figure is representative of three independent
experiments. RLU, relative light units.
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hanced cell transduction through retargeting to HSPG on the
cell surface. This suggests that coagulation factors play a broad
role in dictating adenovirus tropism when exposure to blood
occurs, since subgroup C- (15, 16), subgroup B- (16), and now
subgroup D-based viruses are all sensitive to FX binding. This
is in contrast to a recent finding that Ad5 (and other subgroup
C viruses) but not representative viruses from all other sub-
groups used lactoferrin as a bridge for coxsackie virus and
adenovirus receptor-independent transduction of A549 cells
(10). This demonstrates that research into coagulation factors
and other proteins that can target the Ad capsid proteins in
vivo (either following localized exposure in the case of tear
fluid and lactoferrin [10] or via exposure to the bloodstream) is
warranted, since this has fundamental implications for recep-
tor utilization and infectivity in vivo.
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